FICHIT

Je m'inscris

PROTIPMEDICAL

0/5 (0 note(s))
Note donnée : aucune
Paris
0
Protip imagines and develops breakthrough medical devices to treat widespread larynx disease
NewBreez device is addressing patients who suffer from repeated aspirations. Aspirations is a common condition that can follow stroke, neurodegenerative disease or larynx cancer. NewBreez is CE marked and is currently under clinical trial in various European countries.
BERENGER Maurice
www.protipmedical.com
Private Equity

Fiche créée le 10/04/2016 par Guillaume   vue 7 fois.